Erythema multiforme‐like eruption in patients with COVID‐19 infection: clinical and histological findings

Saved in:
Bibliographic Details
Published inClinical and experimental dermatology Vol. 45; no. 7; pp. 892 - 895
Main Authors Jimenez‐Cauhe, J., Ortega‐Quijano, D., Carretero‐Barrio, I., Suarez‐Valle, A., Saceda‐Corralo, D., Moreno‐Garcia del Real, C., Fernandez‐Nieto, D.
Format Journal Article
LanguageEnglish
Published England Oxford University Press 01.10.2020
Blackwell Publishing Ltd
Subjects
Adrenal Cortex Hormones - therapeutic use
Aged
Anti-Bacterial Agents - therapeutic use
Antiviral Agents - therapeutic use
Azithromycin - therapeutic use
C-Reactive Protein - metabolism
Ceftriaxone - therapeutic use
Correspondence
COVID-19
COVID-19 - blood
COVID-19 - drug therapy
COVID-19 - pathology
COVID-19 - physiopathology
Drug Combinations
Erythema
Erythema multiforme
Erythema Multiforme - blood
Erythema Multiforme - drug therapy
Erythema Multiforme - pathology
Female
Fibrin Fibrinogen Degradation Products - metabolism
Hospitalization
Humans
Hydroxychloroquine - therapeutic use
Lopinavir - therapeutic use
Lymphocyte Count
Middle Aged
Ritonavir - therapeutic use
Viewpoints in Dermatology
Online AccessGet full text

Cover

More Information
Bibliography:Conflict of interest: the authors declare that they have no conflicts of interest.
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ObjectType-Correspondence-1
ISSN:0307-6938
1365-2230
1365-2230
DOI:10.1111/ced.14281